{
  "pmid": "36257548",
  "uid": "36257548",
  "title": "Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Gallagher",
      "fore_name": "Jason C",
      "initials": "JC",
      "name": "Jason C Gallagher",
      "affiliations": [
        "Temple University, School of Pharmacy, Philadelphia, Pennsylvania, USA. Electronic address: jason.gallagher@temple.edu."
      ]
    },
    {
      "last_name": "Morgan",
      "fore_name": "Rebecca L",
      "initials": "RL",
      "name": "Rebecca L Morgan",
      "affiliations": [
        "Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA."
      ]
    }
  ],
  "journal": {
    "title": "Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases",
    "iso_abbreviation": "Clin Microbiol Infect",
    "issn": "1469-0691",
    "issn_type": "Electronic",
    "volume": "29",
    "issue": "1",
    "pub_year": "2023",
    "pub_month": "Jan"
  },
  "start_page": "7",
  "end_page": "9",
  "pages": "7-9",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Comment"
  ],
  "keywords": [
    "Humans",
    "COVID-19",
    "SARS-CoV-2",
    "Immunologic Factors",
    "Treatment Outcome"
  ],
  "article_ids": {
    "pubmed": "36257548",
    "pmc": "PMC9575309",
    "doi": "10.1016/j.cmi.2022.10.016",
    "pii": "S1198-743X(22)00530-4"
  },
  "doi": "10.1016/j.cmi.2022.10.016",
  "pmc_id": "PMC9575309",
  "dates": {
    "completed": "2022-12-27",
    "revised": "2024-09-09"
  },
  "chemicals": [
    "Immunologic Factors"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:45:41.171191",
    "pmid": "36257548"
  }
}